Monday, December 19, 2016

UPDATE 3-Clovis's ovarian cancer drug wins accelerated FDA approval

* Shares soar as much as 26 pct

(Adds Lynparza sales and Rubraca sales estimate)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)